Stereoselective interaction between the CYP2C8 inhibitor gemfibrozil and racemic ibuprofen

被引：0
|
作者：
Aleksi Tornio
Mikko Niemi
Pertti J. Neuvonen
Janne T. Backman
机构：
[1] University of Helsinki,Department of Clinical Pharmacology
来源：
European Journal of Clinical Pharmacology | 2007年 / 63卷
关键词：
CYP2C8; Drug interaction; Gemfibrozil; Ibuprofen enantiomers; Stereoselectivity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：463 / 469
页数：6
相关论文
共 50 条
  • [41] Evaluation of the Relationship Between Polymorphisms in CYP2C8 and CYP2C9 and the Pharmacokinetics of Celecoxib
    Prieto-Perez, Rocio
    Ochoa, Dolores
    Cabaleiro, Teresa
    Roman, Manuel
    Sanchez-Rojas, Sergio Daniel
    Talegon, Maria
    Abad-Santos, Francisco
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (12): : 1261 - 1267
  • [42] THE IMPACT OF A CYP2C8-CYP3A4 PROTEIN-PROTEIN INTERACTION ON TIME DEPENDENT INHIBITION OF CYP2C8
    Whitcher-Johnstone, Andrea
    Chan, Tom S.
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S30 - S30
  • [43] Gemfibrozil Markedly Increases the Plasma Concentrations of Montelukast: A Previously Unrecognized Role for CYP2C8 in the Metabolism of Montelukast
    Karonen, T.
    Filppula, A.
    Laitila, J.
    Niemi, M.
    Neuvonen, P. J.
    Backman, J. T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (02) : 223 - 230
  • [44] CYP2C8 and antimalaria drug efficacy
    Gill, J. P.
    Berglund, E. Gil
    PHARMACOGENOMICS, 2007, 8 (02) : 187 - 198
  • [45] A STUDY OF THE EFFECTS OF INHIBITION OF CYP3A4 BY KETOCONAZOLE (K) AND CYP2C8 BY GEMFIBROZIL (G) ON THE PHARMACOKINETICS DABRAFENIB (D)
    Suttle, B.
    Grossmann, K.
    Richards-Peterson, L.
    Ouellet, D.
    Aktan, G.
    Gordon, M.
    LoRusso, P.
    Infante, J. R.
    Sharma, S.
    Kendra, K.
    Patel, M.
    Pant, S.
    Arkenau, H.
    Middleton, M. R.
    Blackman, S. C.
    Carson, S. W.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S89 - S90
  • [46] The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects
    Niemi, M
    Kajosaari, LI
    Neuvonen, M
    Backman, JT
    Neuvonen, PJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 57 (04) : 441 - 447
  • [47] Identification of a novel carbamoyl glucuronide as a metabolism-dependent inhibitor of CYP2C8
    Kazmi, Faraz
    Smith, Brian
    Hvenegaard, Mette G.
    Bendahl, Lene
    Gipson, Amy
    Buckley, David
    Ogilvie, Brian
    Parkinson, Andrew
    DRUG METABOLISM REVIEWS, 2010, 42 : 143 - +
  • [48] Human CYP2C8: Structure, Substrate Specificity, Inhibitor Selectivity, Inducers and Polymorphisms
    Lai, Xin-Sheng
    Yang, Li-Ping
    Li, Xiao-Tian
    Liu, Jun-Ping
    Zhou, Zhi-Wei
    Zhou, Shu-Feng
    CURRENT DRUG METABOLISM, 2009, 10 (09) : 1009 - 1047
  • [49] Are Cytochrome P450 CYP2C8 and CYP2C9 Polymorphisms Associated with Ibuprofen Response in Very Preterm Infants?
    Durrmeyer, Xavier
    Hovhannisyan, Shushanik
    Medard, Yves
    Jacqz-Aigrain, Evelyne
    Decobert, Fabrice
    Barre, Jerome
    Alberti, Corinne
    Aujard, Yannick
    Danan, Claude
    Baud, Olivier
    PLOS ONE, 2010, 5 (08):
  • [50] Genetic polymorphisms of CYP2C8 in Japanese population
    Nakajima, M
    Fujiki, Y
    Noda, K
    Ohtsuka, H
    Ohkuni, H
    Kyo, S
    Inoue, M
    Kuroiwa, Y
    Yokoi, T
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (06) : 687 - 690
12345